Merck & Co is looking to improve its neurology pipeline via a deal with Teijin Pharma to develop a new tau-targeting antibody. The tau protein is implicated in a number of nervous system ...

In the company’s exhibit, Teijin will present its high-performance materials and composites technologies that can improve manufacturing cycle times, reduce environmental impact and improve consumer ...

Teijin Pharma is part of Teijin Group, a multinational offering services in high-performance materials, healthcare including pharma and IT. It comprises more than 170 companies and employs 20,000 ...